{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:34:58Z","timestamp":1787164498024,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    IL22 is a cytokine with many immunoregulatory effects. It also promotes mucus production, cell proliferation and wound healing, making it a key component of intestinal health. An increasing body of studies highlight the potential of IL22 as a therapeutic drug against NAFLD through the induction of antimicrobial peptides, especially of the Reg3 lectins family, and the regulation of gut microbiota. However, adverse reactions to this molecule in long term administration are little-studied. In this study, we gave daily doses of recombinant\n                    <jats:italic>L. lactis<\/jats:italic>\n                    delivering DNA vaccine for REG3A and IL-22 production to mice fed with a butter-based high fat diet (milk-fat diet or MFD). We aim to compare the effects of REG3A and IL-22 expression by the epithelial cells on the development of obesity-related conditions and the composition of the microbiota. We show that they have opposite effects on fat accumulation in the liver and insulin resistance development despite inducing a similar shift in fecal microbiota composition. Here, we provide evidence that daily long term administration of IL22 can aggravate NAFLD by mechanisms independent from gut microbiota.\n                  <\/jats:p>","DOI":"10.1038\/s41598-024-84700-w","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:00:07Z","timestamp":1759237207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["REG3A and IL22 have opposite effects on fat accumulation in the liver in a high-fat diet"],"prefix":"10.1038","volume":"15","author":[{"given":"Esther Borras","family":"Nogues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Auger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisson","family":"Agus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lia","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Chain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Graci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Langella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Chatel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"84700_CR1","doi-asserted-by":"publisher","unstructured":"Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913\u2013916 e917, (2012). https:\/\/doi.org\/10.1053\/j.gastro.2012.06.031","DOI":"10.1053\/j.gastro.2012.06.031"},{"key":"84700_CR2","doi-asserted-by":"publisher","first-page":"8848","DOI":"10.1038\/s41598-020-65051-8","volume":"10","author":"X Pan","year":"2020","unstructured":"Pan, X., Wen, S. W., Kaminga, A. C. & Liu, A. Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Sci. Rep. 10, 8848. https:\/\/doi.org\/10.1038\/s41598-020-65051-8 (2020).","journal-title":"Sci. Rep."},{"key":"84700_CR3","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1038\/srep05922","volume":"4","author":"M Ellekilde","year":"2014","unstructured":"Ellekilde, M. et al. Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice. Sci. Rep. 4, 5922. https:\/\/doi.org\/10.1038\/srep05922 (2014).","journal-title":"Sci. Rep."},{"key":"84700_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1126\/science.1209791","volume":"334","author":"S Vaishnava","year":"2011","unstructured":"Vaishnava, S. et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334, 255\u2013258. https:\/\/doi.org\/10.1126\/science.1209791 (2011).","journal-title":"Science"},{"key":"84700_CR5","doi-asserted-by":"publisher","unstructured":"Guo, X. et al. High Fat Diet alters gut microbiota and the expression of paneth cell-antimicrobial peptides preceding changes of circulating inflammatory cytokines. Mediators Inflamm. 2017 (9474896). https:\/\/doi.org\/10.1155\/2017\/9474896 (2017).","DOI":"10.1155\/2017\/9474896"},{"key":"84700_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/jcp.24438","volume":"229","author":"V Secq","year":"2014","unstructured":"Secq, V. et al. PAP\/HIP protein is an obesogenic factor. J. Cell. Physiol. 229, 225\u2013231. https:\/\/doi.org\/10.1002\/jcp.24438 (2014).","journal-title":"J. Cell. Physiol."},{"key":"84700_CR7","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/ibd.22929","volume":"18","author":"A Mizoguchi","year":"2012","unstructured":"Mizoguchi, A. Healing of intestinal inflammation by IL-22. Inflamm. Bowel Dis. 18, 1777\u20131784. https:\/\/doi.org\/10.1002\/ibd.22929 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"84700_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbrep.2017.10.003","volume":"12","author":"C Tsuchida","year":"2017","unstructured":"Tsuchida, C. et al. Expression of REG family genes in human inflammatory bowel diseases and its regulation. Biochem. Biophys. Rep. 12, 198\u2013205. https:\/\/doi.org\/10.1016\/j.bbrep.2017.10.003 (2017).","journal-title":"Biochem. Biophys. Rep."},{"key":"84700_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13578-015-0060-8","volume":"5","author":"R Sabat","year":"2015","unstructured":"Sabat, R. & Wolk, K. Deciphering the role of interleukin-22 in metabolic alterations. Cell. Biosci. 5, 68. https:\/\/doi.org\/10.1186\/s13578-015-0060-8 (2015).","journal-title":"Cell. Biosci."},{"key":"84700_CR10","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.2337\/db13-1511","volume":"63","author":"E Dalmas","year":"2014","unstructured":"Dalmas, E. et al. T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: Relevance to obesity and type 2 diabetes. Diabetes 63, 1966\u20131977. https:\/\/doi.org\/10.2337\/db13-1511 (2014).","journal-title":"Diabetes"},{"key":"84700_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jhep.2010.03.004","volume":"53","author":"L Yang","year":"2010","unstructured":"Yang, L. et al. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J. Hepatol. 53, 339\u2013347. https:\/\/doi.org\/10.1016\/j.jhep.2010.03.004 (2010).","journal-title":"J. Hepatol."},{"key":"84700_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature13564","volume":"514","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514, 237\u2013241. https:\/\/doi.org\/10.1038\/nature13564 (2014).","journal-title":"Nature"},{"key":"84700_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/nm.3705","volume":"20","author":"SZ Hasnain","year":"2014","unstructured":"Hasnain, S. Z. et al. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress. Nat. Med. 20, 1417\u20131426. https:\/\/doi.org\/10.1038\/nm.3705 (2014).","journal-title":"Nat. Med."},{"key":"84700_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13578-015-0015-0","volume":"5","author":"O Park","year":"2015","unstructured":"Park, O. et al. Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences. Cell. Biosci. 5, 25. https:\/\/doi.org\/10.1186\/s13578-015-0015-0 (2015).","journal-title":"Cell. Biosci."},{"key":"84700_CR15","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.4049\/jimmunol.1300016","volume":"190","author":"LA Zenewicz","year":"2013","unstructured":"Zenewicz, L. A. et al. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J. Immunol. 190, 5306\u20135312. https:\/\/doi.org\/10.4049\/jimmunol.1300016 (2013).","journal-title":"J. Immunol."},{"key":"84700_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4049\/immunohorizons.1800006","volume":"2","author":"LA Zenewicz","year":"2018","unstructured":"Zenewicz, L. A. IL-22: There is a gap in our knowledge. Immunohorizons 2, 198\u2013207. https:\/\/doi.org\/10.4049\/immunohorizons.1800006 (2018).","journal-title":"Immunohorizons"},{"key":"84700_CR17","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1128\/IAI.66.7.3183-3189.1998","volume":"66","author":"L Steidler","year":"1998","unstructured":"Steidler, L. et al. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect. Immun. 66, 3183\u20133189. https:\/\/doi.org\/10.1128\/IAI.66.7.3183-3189.1998 (1998).","journal-title":"Infect. Immun."},{"key":"84700_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nbt840","volume":"21","author":"L Steidler","year":"2003","unstructured":"Steidler, L. et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 21, 785\u2013789. https:\/\/doi.org\/10.1038\/nbt840 (2003).","journal-title":"Nat. Biotechnol."},{"key":"84700_CR19","doi-asserted-by":"publisher","unstructured":"Oh, J. H. et al. Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity. mSphere 5, (2020). https:\/\/doi.org\/10.1128\/mSphere.00183-20","DOI":"10.1128\/mSphere.00183-20"},{"key":"84700_CR20","doi-asserted-by":"publisher","first-page":"2022997","DOI":"10.1080\/19490976.2021.2022997","volume":"14","author":"M Meynier","year":"2022","unstructured":"Meynier, M. et al. AhR\/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms. Gut Microbes. 14, 2022997. https:\/\/doi.org\/10.1080\/19490976.2021.2022997 (2022).","journal-title":"Gut Microbes"},{"key":"84700_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12934-016-0548-x","volume":"15","author":"BM Souza","year":"2016","unstructured":"Souza, B. M. et al. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells. Microb. Cell. Fact. 15, 150. https:\/\/doi.org\/10.1186\/s12934-016-0548-x (2016).","journal-title":"Microb. Cell. Fact."},{"key":"84700_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.omtm.2016.12.005","volume":"4","author":"P Mancha-Agresti","year":"2017","unstructured":"Mancha-Agresti, P. et al. A New Broad Range plasmid for DNA delivery in eukaryotic cells using lactic acid Bacteria: In Vitro and in vivo assays. Mol. Ther. Methods Clin. Dev. 4, 83\u201391. https:\/\/doi.org\/10.1016\/j.omtm.2016.12.005 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"84700_CR23","doi-asserted-by":"crossref","unstructured":"Bermudez-Humaran, L. G. et al. Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice. Appl. Environ. Microbiol. 73, 5300\u20135307, doi:AEM.00295-07 [pii]10.1128\/AEM.00295-07 (2007).","DOI":"10.1128\/AEM.00295-07"},{"key":"84700_CR24","doi-asserted-by":"publisher","first-page":"718564","DOI":"10.3389\/fnut.2021.718564","volume":"8","author":"E Fabersani","year":"2021","unstructured":"Fabersani, E. et al. Lactic acid Bacteria strains differently modulate gut microbiota and metabolic and immunological parameters in High-Fat Diet-Fed mice. Front. Nutr. 8, 718564. https:\/\/doi.org\/10.3389\/fnut.2021.718564 (2021).","journal-title":"Front. Nutr."},{"key":"84700_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-023-10198-9","author":"H Jeong","year":"2023","unstructured":"Jeong, H., Hwang, U. S., Choi, H. & Park, Y. S. Assessing the anti-obesity potential of Lactococcus lactis subsp. lactis CAB701: Modulation of adipocyte differentiation and lipid metabolism in in vitro and in vivo models. Probiotics Antimicrob. Proteins. https:\/\/doi.org\/10.1007\/s12602-023-10198-9 (2023).","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"84700_CR26","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1038\/ncomms6648","volume":"5","author":"A Everard","year":"2014","unstructured":"Everard, A. et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat. Commun. 5, 5648. https:\/\/doi.org\/10.1038\/ncomms6648 (2014).","journal-title":"Nat. Commun."},{"key":"84700_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.chom.2016.01.003","volume":"19","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing Mucosa-Associated Microbiota and preventing bacterial translocation. Cell. Host Microbe. 19, 227\u2013239. https:\/\/doi.org\/10.1016\/j.chom.2016.01.003 (2016).","journal-title":"Cell. Host Microbe"},{"key":"84700_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/hep4.1165","volume":"2","author":"S Bluemel","year":"2018","unstructured":"Bluemel, S. et al. The role of intestinal C-type regenerating islet Derived-3 lectins for Nonalcoholic Steatohepatitis. Hepatol. Commun. 2, 393\u2013406. https:\/\/doi.org\/10.1002\/hep4.1165 (2018).","journal-title":"Hepatol. Commun."},{"key":"84700_CR29","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","volume":"68","author":"T Hendrikx","year":"2019","unstructured":"Hendrikx, T. et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut 68, 1504\u20131515. https:\/\/doi.org\/10.1136\/gutjnl-2018-317232 (2019).","journal-title":"Gut"},{"key":"84700_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jcmgh.2019.02.006","volume":"8","author":"Y Xiao","year":"2019","unstructured":"Xiao, Y. et al. Interleukin-33 promotes REG3gamma expression in intestinal epithelial cells and regulates gut microbiota. Cell. Mol. Gastroenterol. Hepatol. 8, 21\u201336. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.02.006 (2019).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"84700_CR31","doi-asserted-by":"publisher","first-page":"e5370","DOI":"10.1371\/journal.pone.0005370","volume":"4","author":"J Guo","year":"2009","unstructured":"Guo, J., Jou, W., Gavrilova, O. & Hall, K. D. Persistent diet-induced obesity in male C57BL\/6 mice resulting from temporary obesigenic diets. PLoS One. 4, e5370. https:\/\/doi.org\/10.1371\/journal.pone.0005370 (2009).","journal-title":"PLoS One"},{"key":"84700_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/apt.13216","volume":"42","author":"ZG Jiang","year":"2015","unstructured":"Jiang, Z. G. et al. Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States. Aliment. Pharmacol. Ther. 42, 106\u2013116. https:\/\/doi.org\/10.1111\/apt.13216 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"84700_CR33","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41423-018-0055-6","volume":"16","author":"B Gao","year":"2019","unstructured":"Gao, B. & Xiang, X. Interleukin-22 from bench to bedside: A promising drug for epithelial repair. Cell. Mol. Immunol. 16, 666\u2013667. https:\/\/doi.org\/10.1038\/s41423-018-0055-6 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"84700_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00109-016-1391-6","volume":"94","author":"M Perusina Lanfranca","year":"2016","unstructured":"Perusina Lanfranca, M., Lin, Y., Fang, J., Zou, W. & Frankel, T. Biological and pathological activities of interleukin-22. J. Mol. Med. (Berl). 94, 523\u2013534. https:\/\/doi.org\/10.1007\/s00109-016-1391-6 (2016).","journal-title":"J. Mol. Med. (Berl)"},{"key":"84700_CR35","doi-asserted-by":"publisher","first-page":"e23737","DOI":"10.1371\/journal.pone.0023737","volume":"6","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22. PLoS One. 6, e23737. https:\/\/doi.org\/10.1371\/journal.pone.0023737 (2011).","journal-title":"PLoS One"},{"key":"84700_CR36","doi-asserted-by":"publisher","unstructured":"Gong, F. et al. Interleukin-22 might act as a double-edged sword in Type 2 diabetes and coronary artery disease. Mediators Inflamm 8254797, (2016). https:\/\/doi.org\/10.1155\/2016\/8254797 (2016).","DOI":"10.1155\/2016\/8254797"},{"key":"84700_CR37","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/hep.26916","volume":"59","author":"J Zhao","year":"2014","unstructured":"Zhao, J. et al. Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology 59, 1331\u20131342. https:\/\/doi.org\/10.1002\/hep.26916 (2014).","journal-title":"Hepatology"},{"key":"84700_CR38","doi-asserted-by":"publisher","unstructured":"Fabbrini, E. et al. Association between specific adipose tissue CD4\u2009+\u2009T-cell populations and insulin resistance in obese individuals. Gastroenterology 145, 366\u2013374 e361-363, (2013). https:\/\/doi.org\/10.1053\/j.gastro.2013.04.010","DOI":"10.1053\/j.gastro.2013.04.010"},{"key":"84700_CR39","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2018.03.005","volume":"24","author":"AM Mirea","year":"2018","unstructured":"Mirea, A. M., Tack, C. J., Chavakis, T., Joosten, L. A. B. & Toonen, E. J. M. IL-1 family cytokine pathways underlying NAFLD: Towards new treatment strategies. Trends Mol. Med. 24, 458\u2013471. https:\/\/doi.org\/10.1016\/j.molmed.2018.03.005 (2018).","journal-title":"Trends Mol. Med."},{"key":"84700_CR40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 9, 671\u2013675. https:\/\/doi.org\/10.1038\/nmeth.2089 (2012).","journal-title":"Nat. Methods"},{"key":"84700_CR41","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1128\/aem.63.7.2802-2813.1997","volume":"63","author":"JJ Godon","year":"1997","unstructured":"Godon, J. J., Zumstein, E., Dabert, P., Habouzit, F. & Moletta, R. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl. Environ. Microbiol. 63, 2802\u20132813. https:\/\/doi.org\/10.1128\/aem.63.7.2802-2813.1997 (1997).","journal-title":"Appl. Environ. Microbiol."},{"key":"84700_CR42","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","volume":"46","author":"E Afgan","year":"2018","unstructured":"Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537\u2013W544. https:\/\/doi.org\/10.1093\/nar\/gky379 (2018).","journal-title":"Nucleic Acids Res."},{"key":"84700_CR43","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/bioinformatics\/btx791","volume":"34","author":"F Escudie","year":"2018","unstructured":"Escudie, F. et al. FROGS: Find, rapidly, OTUs with Galaxy Solution. Bioinf.. 34, 1287\u20131294. https:\/\/doi.org\/10.1093\/bioinformatics\/btx791 (2018).","journal-title":"Bioinf."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84700-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84700-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84700-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T01:03:56Z","timestamp":1759626236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84700-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84700"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84700-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33733"}}